On the public citation graph
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
0 signed · 1020 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
2 of the 54 references listed on this page are in the Retraction Watch database as retracted (export 2026-10-28): 10.1016/j.cell.2009.03.047 (notice 2015-04-09), 10.1158/0008-5472.can-09-4598 (notice 2018-09-14).
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s12032-010-9515-2openalex-snapshot
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
inferredcites →https://doi.org/10.1016/1074-7613(94)90087-6openalex-snapshot
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors
inferredcites →https://doi.org/10.1016/j.ccr.2012.02.022openalex-snapshot
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
inferredcites →https://doi.org/10.1016/j.ceb.2013.01.008openalex-snapshot
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
inferredcites →https://doi.org/10.1016/j.cell.2009.03.047openalex-snapshot
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
inferredcites →https://doi.org/10.1016/j.molcel.2010.05.018openalex-snapshot
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
inferredcites →https://doi.org/10.1016/j.molcel.2010.08.013openalex-snapshot
Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
inferredcites →https://doi.org/10.1016/s0065-2776(07)96002-2openalex-snapshot
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
inferredcites →https://doi.org/10.1038/cmi.2010.28openalex-snapshot
Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
inferredcites →https://doi.org/10.1038/embor.2008.74openalex-snapshot
A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells
inferredcites →https://doi.org/10.1038/nature13385openalex-snapshot
Comprehensive molecular profiling of lung adenocarcinoma
inferredcites →https://doi.org/10.1038/ncb1722openalex-snapshot
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
inferredcites →https://doi.org/10.1038/ncb1998openalex-snapshot
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
inferredcites →https://doi.org/10.1038/ncomms3427openalex-snapshot
Tumour angiogenesis regulation by the miR-200 family
inferredcites →https://doi.org/10.1038/ncomms3612openalex-snapshot
Inferring tumour purity and stromal and immune cell admixture from expression data
inferredcites →https://doi.org/10.1038/nm730openalex-snapshot
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
inferredcites →https://doi.org/10.1038/nrc3245openalex-snapshot
The immune contexture in human tumours: impact on clinical outcome
inferredcites →https://doi.org/10.1038/nri3191openalex-snapshot
Adoptive immunotherapy for cancer: harnessing the T cell response
inferredcites →https://doi.org/10.1038/nri3405openalex-snapshot
Molecular mechanisms of T cell co-stimulation and co-inhibition
inferredcites →https://doi.org/10.1038/sj.onc.1210493openalex-snapshot
A genetic mouse model for metastatic lung cancer with gender differences in survival
inferredcites →https://doi.org/10.1056/nejmoa1200690openalex-snapshot
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
inferredcites →https://doi.org/10.1056/nejmoa1200694openalex-snapshot
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
inferredcites →https://doi.org/10.1056/nejmoa1305133openalex-snapshot
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
inferredcites →https://doi.org/10.1073/pnas.0712237105openalex-snapshot
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
inferredcites →https://doi.org/10.1073/pnas.95.13.7556openalex-snapshot
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
inferredcites →https://doi.org/10.1074/jbc.c800074200openalex-snapshot
The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2
inferredcites →https://doi.org/10.1084/jem.20061800openalex-snapshot
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
inferredcites →https://doi.org/10.1093/nar/29.9.e45openalex-snapshot
A new mathematical model for relative quantification in real-time RT-PCR
inferredcites →https://doi.org/10.1097/coh.0b013e32834ddcf2openalex-snapshot
Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells
inferredcites →https://doi.org/10.1097/pai.0b013e3181b6a741openalex-snapshot
A High Number of CD8+ T Cells Infiltrated in NSCLC Tissues is Associated With a Favorable Prognosis
inferredcites →https://doi.org/10.1101/gad.1640608openalex-snapshot
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
inferredcites →https://doi.org/10.1101/gad.1820209openalex-snapshot
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
inferredcites →https://doi.org/10.1101/gad.225334.113openalex-snapshot
Epithelial–mesenchymal plasticity in carcinoma metastasis
inferredcites →https://doi.org/10.1126/scitranslmed.3003689openalex-snapshot
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
inferredcites →https://doi.org/10.1136/gutjnl-2013-306271openalex-snapshot
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity
inferredcites →https://doi.org/10.1158/0008-5472.can-05-4303openalex-snapshot
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
inferredcites →https://doi.org/10.1158/0008-5472.can-08-1942openalex-snapshot
A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
inferredcites →https://doi.org/10.1158/0008-5472.can-09-3153openalex-snapshot
Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non–Small Cell Lung Cancer after Surgical Resection
inferredcites →https://doi.org/10.1158/0008-5472.can-09-4598openalex-snapshot
Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
inferredcites →https://doi.org/10.1158/0008-5472.can-13-2928openalex-snapshot
Foxp3+ T Cells Inhibit Antitumor Immune Memory Modulated by mTOR Inhibition
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-1558openalex-snapshot
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
inferredcites →https://doi.org/10.1158/1541-7786.mcr-10-0497openalex-snapshot
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
inferredcites →https://doi.org/10.1158/2159-8290.cd-13-0310openalex-snapshot
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1172/jci42579openalex-snapshot
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
inferredcites →https://doi.org/10.1172/jci63608openalex-snapshot
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
inferredcites →https://doi.org/10.1172/jci72171openalex-snapshot
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
inferredcites →https://doi.org/10.1200/jco.2012.45.8703openalex-snapshot
Harnessing the Immune System for the Treatment of Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1371/journal.pone.0005401openalex-snapshot
Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma
inferredcites →https://doi.org/10.1371/journal.pone.0012445openalex-snapshot
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
inferredcites →https://doi.org/10.1677/erc-10-0148openalex-snapshot
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
inferredcites →https://doi.org/10.4049/jimmunol.1301317openalex-snapshot
Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous Cytotoxic T Cell Responses to Lung Adenocarcinoma
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4477085openalex-extracted
A Series of Ligustrazine Platinum(Iv) Complexes with Potent Anti-Proliferative and Anti-Metastatic Properties by Causing Chemotherapeutic and Immunotherapeutic Effects
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2018.3115openalex-snapshot
Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification
inferred← citeshttps://doi.org/10.1002/1878-0261.12084openalex-snapshot
Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
inferred← citeshttps://doi.org/10.1002/1878-0261.12085openalex-snapshot
EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities
inferred← citeshttps://doi.org/10.1002/1878-0261.12093openalex-snapshot
New insights into the role of EMT in tumor immune escape
inferred← citeshttps://doi.org/10.1002/1878-0261.12095openalex-snapshot
EMT and inflammation: inseparable actors of cancer progression
inferred← citeshttps://doi.org/10.1002/1878-0261.12571openalex-snapshot
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC
inferred← citeshttps://doi.org/10.1002/1878-0261.12804openalex-snapshot
Rho‐associated protein kinase‐dependent moesin phosphorylation is required for PD‐L1 stabilization in breast cancer
inferred← citeshttps://doi.org/10.1002/adem.202402544openalex-snapshot
Rational Engineering of Nanostructured AgM (M = Au, Pt, Pd) Bimetallic Electrodes via Galvanic Replacement for Glycerol Electrolysis
inferred← citeshttps://doi.org/10.1002/adhm.201901706openalex-snapshot
Enhanced Prevention of Breast Tumor Metastasis by Nanoparticle‐Delivered Vitamin E in Combination with Interferon‐Gamma
inferred← citeshttps://doi.org/10.1002/adma.201802560openalex-snapshot
Soft Electronically Functional Polymeric Composite Materials for a Flexible and Stretchable Digital Future
inferred← citeshttps://doi.org/10.1002/adma.202517019openalex-snapshot
Emerging Biomaterials Blocking PD‐1/PD‐L1 Pathway for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/admt.202001023openalex-snapshot
Recent Progress on Flexible Capacitive Pressure Sensors: From Design and Materials to Applications
inferred← citeshttps://doi.org/10.1002/adpr.202300155openalex-snapshot
Direct Determination of Photonic Stopband Topological Character: A Framework Based on Dispersion Measurements
inferred← citeshttps://doi.org/10.1002/adsc.202100571openalex-snapshot
Enantioselective Synthesis of Spirothiazolones via Cooperative Catalysis
inferred← citeshttps://doi.org/10.1002/aisy.202000039openalex-snapshot
Wearable and Stretchable Strain Sensors: Materials, Sensing Mechanisms, and Applications
inferred← citeshttps://doi.org/10.1002/ange.202214750openalex-snapshot
PD‐L1 Aptamer‐Functionalized Metal–Organic Framework Nanoparticles for Robust Photo‐Immunotherapy against Cancer with Enhanced Safety
inferred← citeshttps://doi.org/10.1002/anie.202214750openalex-snapshot
PD‐L1 Aptamer‐Functionalized Metal–Organic Framework Nanoparticles for Robust Photo‐Immunotherapy against Cancer with Enhanced Safety
inferred← citeshttps://doi.org/10.1002/cam4.1564openalex-snapshot
Epithelial‐mesenchymal transition‐converted tumor cells can induce T‐cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.3410openalex-snapshot
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
inferred← citeshttps://doi.org/10.1002/cam4.6843openalex-snapshot
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study
inferred← citeshttps://doi.org/10.1002/cbf.4010openalex-snapshot
Adenosine increases PD‐L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF‐β1
inferred← citeshttps://doi.org/10.1002/cctc.202500152openalex-snapshot
Progress and Challenges in Electrochemical Glycerol Oxidation: The Importance of Benchmark Methods and Protocols
inferred← citeshttps://doi.org/10.1002/chem.202400499openalex-snapshot
Room Temperature Phosphorescence in Crystalline Iodinated Eumelanin Monomer
inferred← citeshttps://doi.org/10.1002/cncr.33135openalex-snapshot
Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated
inferred← citeshttps://doi.org/10.1002/cncr.34782openalex-snapshot
Vimentin expression correlates with immune checkpoint inhibitor efficacy in non–small cell lung cancer
inferred← citeshttps://doi.org/10.1002/ctm2.1186openalex-snapshot
MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell‐mediated cytolysis
inferred← citeshttps://doi.org/10.1002/dvdy.24485openalex-snapshot
Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas
inferred← citeshttps://doi.org/10.1002/dvdy.24506openalex-snapshot
Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases
inferred← citeshttps://doi.org/10.1002/dvdy.24596openalex-snapshot
Prospects for new lung cancer treatments that target EMT signaling
inferred← citeshttps://doi.org/10.1002/elsa.202100174openalex-snapshot
Glycerol electro‐reforming in alkaline electrolysis cells for the simultaneous production of value‐added chemicals and pure hydrogen – Mini‐review
inferred← citeshttps://doi.org/10.1002/ente.202200134openalex-snapshot
Enhanced Hydrogen Production during Electro‐Oxidation of Ethanol using Plasmonic Gold Nanoparticles
inferred← citeshttps://doi.org/10.1002/gcc.22725openalex-snapshot
Role of miRNAs in immune responses and immunotherapy in cancer
inferred← citeshttps://doi.org/10.1002/gcc.23216openalex-snapshot
Polymorphisms of the PD‐L1 gene 3′‐untranslated region are associated with the expression of PD‐L1 in non‐small cell lung cancer
inferred← citeshttps://doi.org/10.1002/hep.28710openalex-snapshot
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
inferred← citeshttps://doi.org/10.1002/hep4.1682openalex-snapshot
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1
inferred← citeshttps://doi.org/10.1002/ijc.34127openalex-snapshot
Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications
inferred← citeshttps://doi.org/10.1002/jbt.23719openalex-snapshot
Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes
inferred← citeshttps://doi.org/10.1002/jbt.70985openalex-snapshot
MAPK12 Upregulates PD‐L1 Expression in Hepatocellular Carcinoma to Induce Immune Suppression Through the PI3K/AKT/mTOR Pathway
inferred← citeshttps://doi.org/10.1002/jcb.30273openalex-snapshot
CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
inferred← citeshttps://doi.org/10.1002/jcp.27172openalex-snapshot
PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
inferred← citeshttps://doi.org/10.1002/jcp.29671openalex-snapshot
Role of tumor microenvironment in the regulation of PD‐L1: A novel role in resistance to cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/jrs.6044openalex-snapshot
Event chronology analysis of the historical development of tip‐enhanced Raman spectroscopy
inferred← citeshttps://doi.org/10.1002/kjm2.12212openalex-snapshot
Retracted: Protective effect of hsa‐miR ‐570‐3p targeting CD274 on triple negative breast cancer by blocking PI3K / AKT / mTOR signaling pathway
inferred← citeshttps://doi.org/10.1002/mc.22657openalex-snapshot
The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/mnfr.201700844openalex-snapshot
Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by Downregulating Bmi‐1 Through Enhanced miR‐200c Expression
inferred← citeshttps://doi.org/10.1002/slct.201702478openalex-snapshot
Red‐Emitting Magnetic Nanocomposites Assembled from Ag‐Decorated Fe 3 O 4 @SiO 2 and Y 2 O 3 :Eu 3+ : Impact of Iron‐Oxide/Silver Nanoparticles on Eu 3+ Emission
inferred← citeshttps://doi.org/10.1002/wene.193openalex-snapshot
Electrochemical conversion of alcohols for hydrogen production: a short overview
inferred← citeshttps://doi.org/10.1007/16833_2022_53openalex-snapshot
MicroRNAs in the Immunopathology and Treatment of Non-small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1007/16833_2024_455openalex-snapshot
Clinical Implications of Epithelial-to-Mesenchymal Transition (EMT) in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-8600-2_16openalex-snapshot
Mouse-Derived Gastric Organoid and Immune Cell Co-culture for the Study of the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-1-4939-8979-9_6openalex-snapshot
Identification of Immune Modulatory miRNAs by miRNA Enrichment via RNA Affinity Purification
inferred← citeshttps://doi.org/10.1007/978-3-030-50224-9_1openalex-snapshot
MicroRNAs in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-3-030-98950-7_11openalex-snapshot
Drivers of EMT and Immune Evasion
inferred← citeshttps://doi.org/10.1007/978-3-031-08356-3_3openalex-snapshot
Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-032-08824-6_12openalex-snapshot
MicroRNAs in Lung Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-39147-2_9openalex-snapshot
Drivers of EMT and Immune Evasion
inferred← citeshttps://doi.org/10.1007/978-3-319-53156-4_3openalex-snapshot
Optimizing Radiotherapy with Immunotherapeutic Approaches
inferred← citeshttps://doi.org/10.1007/978-3-319-74470-4_6openalex-snapshot
MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells
inferred← citeshttps://doi.org/10.1007/978-981-10-2002-5_19openalex-snapshot
Targeting Epithelial-Mesenchymal Transition and Cancer Stem Cell
inferred← citeshttps://doi.org/10.1007/978-981-13-1568-8_3openalex-snapshot
Cancer RNome: Evolution and Sustenance
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_11openalex-snapshot
Regulations on Messenger RNA: Wires and Nodes
inferred← citeshttps://doi.org/10.1007/978-981-15-3266-5_3openalex-snapshot
Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
inferred← citeshttps://doi.org/10.1007/978-981-95-5071-5_12openalex-snapshot
Restoring Tumor Suppression Activity: Mimicking Molecules (TargomiRs and MRX34) and Synthetic RNAs (MTL-CEBPA)
inferred← citeshttps://doi.org/10.1007/978-981-95-5989-3_2openalex-snapshot
miRNA Deregulation and Its Role in Progression and Advancement of Cancer
inferred← citeshttps://doi.org/10.1007/978-981-95-8026-2_3openalex-snapshot
Genetic and Epigenetic Regulation of Immune Checkpoints
inferred← citeshttps://doi.org/10.1007/s00018-016-2346-3openalex-snapshot
How cancer cells dictate their microenvironment: present roles of extracellular vesicles
inferred← citeshttps://doi.org/10.1007/s00018-022-04630-6openalex-snapshot
Mechanisms of colorectal liver metastasis development
inferred← citeshttps://doi.org/10.1007/s00018-026-06240-yopenalex-snapshot
Epithelial-mesenchymal transition and immunosuppression: Two sides of the same coin
inferred← citeshttps://doi.org/10.1007/s00204-021-03063-7openalex-snapshot
Cancer drug resistance induced by EMT: novel therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s00210-024-03366-3openalex-snapshot
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
inferred← citeshttps://doi.org/10.1007/s00262-020-02550-7openalex-snapshot
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer
inferred← citeshttps://doi.org/10.1007/s00262-020-02678-6openalex-snapshot
Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer
inferred← citeshttps://doi.org/10.1007/s00262-022-03171-yopenalex-snapshot
CMTM6 as a master regulator of PD-L1
inferred← citeshttps://doi.org/10.1007/s00262-025-03978-5openalex-snapshot
ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma
inferred← citeshttps://doi.org/10.1007/s00428-021-03266-4openalex-snapshot
Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival
inferred← citeshttps://doi.org/10.1007/s00438-024-02199-2openalex-snapshot
Discovering the role of microRNAs and exosomal microRNAs in chest and pulmonary diseases: a spotlight on chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1007/s00438-026-02426-yopenalex-snapshot
miR-133b induces antitumor immunity in cervical cancer through modulating CMTM6/PD-L1 axis
inferred← citeshttps://doi.org/10.1007/s10238-023-01229-4openalex-snapshot
EMT-induced immune evasion: connecting the dots from mechanisms to therapy
inferred← citeshttps://doi.org/10.1007/s10238-023-01274-zopenalex-snapshot
WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses
inferred← citeshttps://doi.org/10.1007/s10238-025-01641-yopenalex-snapshot
PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunities
inferred← citeshttps://doi.org/10.1007/s10528-024-10796-4openalex-snapshot
Impact of Doxorubicin and Docetaxel on Immune Checkpoint Expression in Colorectal Cancer: Insights into Chemotherapy Resistance Mechanisms
inferred← citeshttps://doi.org/10.1007/s10555-017-9716-7openalex-snapshot
Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s10555-021-09979-xopenalex-snapshot
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
inferred← citeshttps://doi.org/10.1007/s10555-023-10141-yopenalex-snapshot
Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance
inferred← citeshttps://doi.org/10.1007/s10555-024-10189-4openalex-snapshot
The roles of PD-L1 in the various stages of tumor metastasis
inferred← citeshttps://doi.org/10.1007/s10555-025-10240-yopenalex-snapshot
The transcription factor FOXQ1 in cancer
inferred← citeshttps://doi.org/10.1007/s10585-018-9906-xopenalex-snapshot
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
inferred← citeshttps://doi.org/10.1007/s10822-026-00801-wopenalex-snapshot
ProVenTL: a transfer-learning framework for predicting peptide–protein interactions derived from snake venom for cancer therapeutics
inferred← citeshttps://doi.org/10.1007/s11010-021-04226-xopenalex-snapshot
Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs
inferred← citeshttps://doi.org/10.1007/s11033-025-11367-5openalex-snapshot
Gatekeepers of immunity: mechanisms and regulation of immune checkpoints and their role in immune-privileged sites
inferred← citeshttps://doi.org/10.1007/s11523-017-0478-5openalex-snapshot
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
inferred← citeshttps://doi.org/10.1007/s11684-018-0656-6openalex-snapshot
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
inferred← citeshttps://doi.org/10.1007/s11684-023-1025-7openalex-snapshot
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
inferred← citeshttps://doi.org/10.1007/s11748-021-01595-4openalex-snapshot
Lung cancer and epithelial-mesenchymal transition
inferred← citeshttps://doi.org/10.1007/s12010-025-05255-8openalex-snapshot
miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1
inferred← citeshttps://doi.org/10.1007/s12032-020-01372-yopenalex-snapshot
PD-L1 upregulation accompanied with epithelial–mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells
inferred← citeshttps://doi.org/10.1007/s12032-023-02099-2openalex-snapshot
Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression
inferred← citeshttps://doi.org/10.1007/s12038-022-00254-xopenalex-snapshot
Cancer: More than a geneticist’s Pandora’s box
inferred← citeshttps://doi.org/10.1007/s12072-023-10572-3openalex-snapshot
Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1–AXL signal relay in liver cancer cells
inferred← citeshttps://doi.org/10.1007/s12253-019-00735-9openalex-snapshot
Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs
inferred← citeshttps://doi.org/10.1007/s12272-017-0951-9openalex-snapshot
Natural killer cells and tumor metastasis
inferred← citeshttps://doi.org/10.1007/s12272-023-01427-4openalex-snapshot
The role and application of transcriptional repressors in cancer treatment
inferred← citeshttps://doi.org/10.1007/s12307-019-00232-2openalex-snapshot
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
inferred← citeshttps://doi.org/10.1007/s12672-025-02054-9openalex-snapshot
MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance
inferred← citeshttps://doi.org/10.1007/s12672-025-03062-5openalex-snapshot
p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1007/s12672-026-04819-2openalex-snapshot
Deciphering the role of glycolipids as emerging therapeutic targets in EMT-driven cancer progression
inferred← citeshttps://doi.org/10.1007/s13402-026-01181-xopenalex-snapshot
Strategies to target PD-1/PD-L1 in the tumor microenvironment
inferred← citeshttps://doi.org/10.1007/s13577-019-00300-1openalex-snapshot
Patterns of immune infiltration in lung adenocarcinoma revealed a prognosis-associated microRNA–mast cells network
inferred← citeshttps://doi.org/10.1007/s40291-023-00652-3openalex-snapshot
Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition
inferred← citeshttps://doi.org/10.1007/s40484-020-0219-0openalex-snapshot
Critical transitions and tipping points in EMT
inferred← citeshttps://doi.org/10.1016/b978-0-12-813209-8.00033-9openalex-snapshot
Phenotypic Plasticity and the Origins and Progression of Ovarian Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00005-0openalex-snapshot
Epithelial to Mesenchymal Transition
inferred← citeshttps://doi.org/10.1016/b978-0-12-823008-4.00002-0openalex-snapshot
Dietary regulation of miRNA in precision medicine of lung cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-823931-5.00018-9openalex-snapshot
Epigenetics of the pathogenic myofibroblast in lung disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-824550-7.00009-6openalex-snapshot
Clinical applications of noncoding RNAs in lung cancer patients
inferred← citeshttps://doi.org/10.1016/b978-0-323-90053-9.00005-1openalex-snapshot
MicroRNAs and their role in immunogenetic-dysregulation
inferred← citeshttps://doi.org/10.1016/b978-0-323-90250-2.00008-xopenalex-snapshot
MicroRNAs as potential immunotherapeutic modulators in cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-45146-1.00018-7openalex-snapshot
The role of epigenetic alterations in lung cancer progression
inferred← citeshttps://doi.org/10.1016/bs.acr.2017.06.002openalex-snapshot
Cancer Hallmarks and MicroRNAs: The Therapeutic Connection
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2019.03.008openalex-snapshot
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.09.010openalex-snapshot
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation
inferred← citeshttps://doi.org/10.1016/j.archoralbio.2024.106043openalex-snapshot
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2021.119144openalex-snapshot
PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression
inferred← citeshttps://doi.org/10.1016/j.bbcan.2017.10.006openalex-snapshot
Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness
inferred← citeshttps://doi.org/10.1016/j.bbcan.2018.10.003openalex-snapshot
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2021.188638openalex-snapshot
The progress of immune checkpoint therapy in primary liver cancer
inferred← citeshttps://doi.org/10.1016/j.bbrc.2017.05.074openalex-snapshot
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity
inferred← citeshttps://doi.org/10.1016/j.bcp.2018.10.031openalex-snapshot
Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids
inferred← citeshttps://doi.org/10.1016/j.biocel.2016.07.011openalex-snapshot
Management of non-small cell lung cancer in the era of personalized medicine
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.11.112openalex-snapshot
The roles of ZEB1 in tumorigenic progression and epigenetic modifications
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112213openalex-snapshot
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113490openalex-snapshot
ZEB1: Catalyst of immune escape during tumor metastasis
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113906openalex-snapshot
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115104openalex-snapshot
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116275openalex-snapshot
Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
inferred← citeshttps://doi.org/10.1016/j.bj.2020.05.010openalex-snapshot
Suppression of MGAT3 expression and the epithelial–mesenchymal transition of lung cancer cells by miR-188-5p
inferred← citeshttps://doi.org/10.1016/j.canlet.2015.12.033openalex-snapshot
Whom to blame for metastasis, the epithelial–mesenchymal transition or the tumor microenvironment?
inferred← citeshttps://doi.org/10.1016/j.canlet.2017.04.006openalex-snapshot
ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.05.015openalex-snapshot
Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins
inferred← citeshttps://doi.org/10.1016/j.canlet.2018.09.019openalex-snapshot
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.05.021openalex-snapshot
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.10.013openalex-snapshot
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.07.004openalex-snapshot
Hypoxia-driven intratumor heterogeneity and immune evasion
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.11.006openalex-snapshot
The double-edged sword of H19 lncRNA: Insights into cancer therapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.12.025openalex-snapshot
Dissecting miRNA signature in colorectal cancer progression and metastasis
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.12.040openalex-snapshot
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2021.05.037openalex-snapshot
miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2023.216318openalex-snapshot
The opportunities and challenges in immunotherapy: Insights from the regulation of PD-L1 in cancer cells
inferred← citeshttps://doi.org/10.1016/j.canlet.2024.216661openalex-snapshot
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
inferred← citeshttps://doi.org/10.1016/j.canlet.2026.218470openalex-snapshot
Coordinated post-transcriptional regulation facilitates PD-L1 protein production and tumor immune suppression
inferred← citeshttps://doi.org/10.1016/j.cca.2018.05.011openalex-snapshot
The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ccell.2021.11.002openalex-snapshot
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
inferred← citeshttps://doi.org/10.1016/j.ccell.2023.01.007openalex-snapshot
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance
inferred← citeshttps://doi.org/10.1016/j.cell.2016.02.065openalex-snapshot
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
inferred← citeshttps://doi.org/10.1016/j.cell.2025.08.033openalex-snapshot
Epithelial-mesenchymal transition
inferred← citeshttps://doi.org/10.1016/j.cellsig.2020.109593openalex-snapshot
Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.07.007openalex-snapshot
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109181openalex-snapshot
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
inferred← citeshttps://doi.org/10.1016/j.celrep.2024.113794openalex-snapshot
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
inferred← citeshttps://doi.org/10.1016/j.cjtee.2023.11.003openalex-snapshot
The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells
inferred← citeshttps://doi.org/10.1016/j.clim.2021.108728openalex-snapshot
Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway
inferred← citeshttps://doi.org/10.1016/j.cllc.2015.11.006openalex-snapshot
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non–Small-Cell Lung Cancer
inferred← citeshttps://doi.org/10.1016/j.cllc.2017.10.014openalex-snapshot
The Significance of the PD-L1 Expression in Non–Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers
inferred← citeshttps://doi.org/10.1016/j.cllc.2020.06.003openalex-snapshot
Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.cllc.2021.09.010openalex-snapshot
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2020.103063openalex-snapshot
Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2024.104332openalex-snapshot
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.06.023openalex-snapshot
Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.12.020openalex-snapshot
miR-4759 suppresses breast cancer through immune checkpoint blockade
inferred← citeshttps://doi.org/10.1016/j.csbj.2023.01.031openalex-snapshot
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2018.08.008openalex-snapshot
Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
inferred← citeshttps://doi.org/10.1016/j.cyto.2026.157177openalex-snapshot
Innovative immune checkpoint modulators: monoclonal antibodies, small molecules, non-coding RNAs, and nanoparticles in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2017.05.003openalex-snapshot
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2017.05.008openalex-snapshot
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2019.07.001openalex-snapshot
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.devcel.2019.04.010openalex-snapshot
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
inferred← citeshttps://doi.org/10.1016/j.devcel.2019.04.012openalex-snapshot
Metastasis Organotropism: Redefining the Congenial Soil
inferred← citeshttps://doi.org/10.1016/j.diff.2025.100903openalex-snapshot
EMT: from embryogenesis, through cancer progression, to the development of carcinosarcoma
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104321openalex-snapshot
Epigenetic code underlying EGFR-TKI resistance in non-small cell lung cancer: Elucidation of mechanisms and perspectives on therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.02.034openalex-snapshot
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103542openalex-snapshot
Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours
inferred← citeshttps://doi.org/10.1016/j.eclinm.2020.100673openalex-snapshot
Predicting Hyperprogressive Disease in Patients with Advanced Hepatocellular Carcinoma Treated with Anti-Programmed Cell Death 1 Therapy
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.101134openalex-snapshot
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ehpc.2020.200356openalex-snapshot
Novel IRF8 and PD-L1 molecular aberrations in systemic EBV-positive T-cell lymphoma of childhood
inferred← citeshttps://doi.org/10.1016/j.ejca.2015.08.013openalex-snapshot
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
inferred← citeshttps://doi.org/10.1016/j.ejca.2022.03.038openalex-snapshot
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.ejcb.2020.151073openalex-snapshot
ROS and oncogenesis with special reference to EMT and stemness
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114234openalex-snapshot
RNA-encapsulating lipid nanoparticles in cancer immunotherapy: From pre-clinical studies to clinical trials
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.173933openalex-snapshot
MiRNA-138–5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis
inferred← citeshttps://doi.org/10.1016/j.gene.2018.05.025openalex-snapshot
Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.gene.2020.144888openalex-snapshot
Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
inferred← citeshttps://doi.org/10.1016/j.gpb.2022.05.001openalex-snapshot
RNA2Immune: A Database of Experimentally Supported Data Linking Non-Coding RNA Regulation to the Immune System
inferred← citeshttps://doi.org/10.1016/j.humpath.2016.07.007openalex-snapshot
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung
inferred← citeshttps://doi.org/10.1016/j.humpath.2018.03.025openalex-snapshot
Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2022.122361openalex-snapshot
Norcantharidin liposome emulsion hybrid delivery system enhances PD-1/PD-L1 immunotherapy by agonizing the non-canonical NF-κB pathway
showing the first 200 of 966 · page through all 966
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.